Abstract The functional significance of the novel estrogen receptor b in brain areas that exclusively contain the ERb receptor subtype such as the paraventricular (PVN) and the supraoptic (SON) nuclei of the hypothalamus is not yet fully understood. The present study attempts to characterize the peptidergic nature of the ERb-containing neuronal population in the PVN and the SON using the double in situ histochemistry method in the female rat. Using this method, the ERb mRNA coexpressions with the novel opioid neuropeptide (orphanin FQ and its receptor ORL1) mRNA in addition to the previously reported neuropeptide (arginine vasopressin-AVP, oxytocin-OXY, corticotropin releasing hormone-CRH, enkephalin-ENK) mRNAs were assessed. In the PVN, roughly half of the ERb expression was colocalized with the prepro-orphanin FQ mRNA, which was comparable to the colocalization observed between the ERb and AVP mRNAs in the same region. In addition, there was 20% overlap between the ERb and ORL1 receptor mRNAs, and 10% overlap between the ERb and OXY mRNAs in the PVN. By contrast, the coexpression between the prepro-orphanin FQ and ERb mRNAs was less striking in the SON. Potential interactions between the ERb and the well-characterized AVP-OXY neurosecretory system as well as the novel OFQ-ORL1 opioid neuropeptide system may provide new leads for the functional significance of ERb, specifically in stress/autonomic responses. 
Introduction
In addition to its widely accepted reproductive function (Larsson and Heimer 1964; Nance et al. 1977; Pfaff and Sakuma 1995) , estrogen is implicated in nonreproductive functions such as cognitive (Birge 1996; Tange et al. 1996) , neuroprotective (Singh et al. 1995; Fader et al. 1998 ) and learning and memory (Luine et al. 1998; Gibbs 2000) . It was thought that the mechanism through which estrogen could activate such nonreproductive functions was more likely to be non-genomic, since the classicallydefined estrogen receptor (ERa) was found to be either low in abundance or absent in regions of the brain that were thought to be important for such functions. More recently, however, a second nuclear estrogen receptor (ERb) was isolated in the prostate and ovary (Kuiper et al. 1996; Kuiper et al. 1998) , cloned and mapped in the rat brain (Shughrue et al. 1997) . In situ hybridization histochemistry of ERa and b mRNAs in consecutive sections showed that although there were some overlaps between the mRNA expressions of the two receptor subtypes in some areas of the rat brain, there were distinct regions such as the olfactory bulb, cortex, the paraventricular (PVN) and the supraoptic (SON) nuclei of the hypothalamus which contained high levels of ERb mRNA and either very scarce or no ERa mRNA (Shughrue et al. 1997) . Moreover, although ERa knock-out mice were greatly impaired in male-or female-typical reproductive behavior, ERb knock-out mice, in contrast, were found to be functionally intact in these behavioral dimensions (Ogawa et al. 1999) . Collectively, these data suggest not only that estrogen, through binding to its own receptors, can activate various brain circuitries and behaviors, but also that the ERb receptor subtype is a good candidate for direct estrogen regulation of behaviors that are not typically linked to reproduction.
The functional significance of the ERb receptor subtype remains to be fully understood. Differential expressions of the ERa and ERb in the brain may be used to shed light on the function of ERb, especially in regions such as the PVN and SON, which are reported to exclusively contain the ERb mRNA (Shughrue et al. 1997) . These two brain regions have been repeatedly implicated in the regulation of stress response, partly via stress-induced arginine vasopressin (AVP) and oxytocin (OXY) release (Jezova et al. 1993; Miyata et al. 1995; Neumann et al. 1995; Rivest and Laflamme 1995) . Using a combined in situ hybridization and immunohistochemistry technique, it has been shown that the ERb mRNA is colocalized with AVP and OXY immunoreactivity in the PVN and the SON, suggesting a significant role for estrogen in regulating these neuropeptides (Hrabovszky et al. 1998; Laflamme et al. 1998) , and by doing so, regulating the hypothalamic-pituitary-adrenal (HPA) axis. The magnitude of any detected colocalization of ERb neurons with AVP and OXY was roughly 40% at best, leaving more than half of the ERb neurons in these brain regions still unidentified in neuropeptide origin.
In the present study, using a double in situ hybridization histochemistry technique, we further investigated the neuropeptidergic characterization of the ERb receptor subtype in the PVN and SON. We asked whether, aside from classical neuropeptides such as AVP, OXY, corticotropin releasing hormone (CRH) and enkephalin (ENK) that are abundantly expressed in the PVN and/or SON, there were other neuropeptides that may critically overlap with the ERb expression in these regions. Another neuropeptide that is chosen as a likely candidate is the orphanin FQ (OFQ), which belongs to the opioid peptide family. The OFQ or nociceptin is a heptadecapeptide (Mollereau et al. 1994; Meunier et al. 1995) , which binds to its own receptor (ORL1) (Mohr and Schmitz 1991) but does not act on , k, d opioid receptor subtypes. The OFQ-ORL1 system was a likely candidate in this investigation since not only were the peptide and its receptor both found abundantly expressed in the PVN and SON (Neal et al. 1999a (Neal et al. , 1999b , but also the distribution of both molecules was very dense in areas that roughly corresponded to the ERb-positive neuronal population. Our present findings indicate that the OFQ and AVP neuropeptide systems may be equally important in their interactions with the estrogen-ERb system in the PVN.
Materials and methods

Animals and experimental procedures
Twenty-four adult female Sprague-Dawley rats, weighing 280-330 g, were purchased from Charles River Laboratories, Wilmington, Mass. Animals were housed, three per cage, in a temperature (23C)-and light (lights on from 0600 to 1800 h)-controlled room with free access to rat chow and tap water. Animals were housed at housing conditions for at least 7 days before any experimental manipulation and treated in accordance with the National Institute of Health guidelines on laboratory animal use and care. The oestrus cycle was assessed via vaginal smears, and only rats in diestrus 1 when gonadal hormone levels were at basal, were used in the study.
Animals were killed by rapid decapitation around 9:00 A.M. The brains were removed and frozen in isopentane (-40C) , and stored at -80C. The frozen brains were sectioned using a cryostat. Thin (20 m), coronal brain sections were cut, from Bregma 1.4 to 1.6 mm for the SON, and from Bregma 1.6 to 1.8 mm for the PVN, then thaw-mounted onto poly-lysine-subbed glass slides, and stored at -80C until used. Four animals and 3-4 sections per animal were used for each double in situ probe combination for percentage calculations.
In situ hybridization histochemistry Sections were removed from the -80C freezer, fixed in 4% paraformaldehyde for 1 h, and rinsed three times in 2X SSC (1X SSC: 0.15 M NaCl, 0.015 M Na citrate, pH 7.2). Then the sections were placed in a solution containing acetic anhydride (0.25%) in triethanolamine (0.1 M, pH 8.0) at room temperature for 10 min, rinsed in distilled water, and dehydrated through graded ethanol (50, 70, 80, 95, and 100%) , and subsequently air-dried. The 35 Slabeled antisense cRNA probe for estrogen b receptor [360 base pairs (bp)] was transcribed via incubation with the transcription enzyme T3 (ERb mRNA was generously donated by GGJM Kuiper) . The digoxigenin-labeled antisense cRNA probes for prepro-OFQ (580 bp), ORL1 (700 bp), CRH (680 bp), enkephalin (ENK, 693 bp), AVP (235 bp) and OXY (524 bp) were prepared with digoxigenin-UTP (Dig-UTP; Boehringer Mannheim, Indianapolis) and transcribed using the SP6 (for prepro-OFQ, AVP, OXY) or the T7 (for ORL1, CRH, ENK) transcription enzymes. Brain sections were hybridized overnight with both probes at 55C. After hybridization, coverslips were removed and slides were rinsed three times in 2X SSC, and incubated in RNase A (20 g/ml) at 37C for 1 h. Slides were washed sequentially in 2X SSC, 1X SSC, 0.5X SSC, and 0.1X SSC for 5 min and 0.1X SSC at 65C for 1 h, and then processed for visualization of the Dig-labeled probe. Briefly, sections were incubated overnight with an antibody against Dig, conjugated to alkaline phosphatase (sheep anti-dig-AP; Fab fragments; Boehringer Mannheim), diluted 1:20,000. After extensive washing, sections underwent a color reaction by addition of 0.45% nitro blue tetrazolium chloride (Boehringer) and 0.35% 5-bromo-4-chloro-3-indoylphosphate, 4-toluidine salt (Boehringer). After completion of the color reaction (8-24 h) sections were rinsed and stripped of antibody by incubation with 0.1 M glycine and 0.5% Triton-X 100, pH 2.2, for 10 min. Finally sections were fixed in 2.5% glutaraldehyde for 1-2 h, and then dehydrated through a graded series of ethanol. After exposure to Kodak XAR film (Eastman Kodak, Rochester, NY), sections were dipped in liquid emulsion (Ilford KD-5; Polysciences, Warrington, Pa.) and stored in light-tight boxes for 21-30 days. Hereafter, sections were developed (Kodak D-19; Eastman Kodak, Rochester, NY), dehydrated, and coverslipped in a xylene-based mounting medium (Permount). The cellular distribution was determined using a Leica (Leitz, Nussloch, Germany;) microscope. Nonradioactive probes (prepro-OFQ, ORL1, CRH, ENK, AVP and OXY) were visualized under the bright-field illumination as a blue-purple precipitate, whereas the radioactive probe (ERb) was visualized under the darkfield illumination as silver grain distribution. It should be noted that the nonradioactive in situ hybridization technique is less sensitive than the radioactive one, hence the dig-labeled cell population tends to be under-represented. All combinations of radioactive and nonradioactive probes were analyzed.
Cell profile counts were determined at 60X or 100X magnification, with the aid of an eyepiece grid. No attempt was made to establish absolute numbers of cells within these structures. Rather, the numbers of cell profiles counted for each animal were used to approximate the relative percent colocalization of mRNA for each animal.
Photography and image processing
Cell counts were performed on digitized images. Bright-field and dark-field images were captured with a Sony CCD video camera (DXC-970MD, Sony, Tokyo, Japan) attached to a Leica (Leitz,) microscope using the Micro Computer Imaging Device (Ontario, Canada) image analysis system. Composites were formed within Adobe Photoshop 5.5. Brightness and contrast were slightly altered to generate photographic quality prints.
Results
In all of the analyses below, sections corresponding to the PVN are restricted to Bregma 1.6 to 1.8 mm, because the ERb mRNA signal is most abundantly detected at this rostro-caudal level.
Colocalization between ERb and AVP
The ERb mRNA radioactive signal within the PVN is found concentrated in the ventromedial PVN (the transitional zone between the magno-and parvocellular regions), whereas the AVP mRNA nonradioactive (digoxigenin) signal is found concentrated mainly in the magnocellular region ( Fig. 2A, B) . Dual in situ hybridization revealed that 45 € 3% of the ERb cells in this region also expressed the AVP mRNA, whereas in the same sections, 20 € 2% of AVP mRNA-positive cells also showed radioactive labeling for the ERb mRNA (Fig. 1A,  Fig. 2C ). The total number of AVP mRNA-positive cells counted under bright-field illumination was roughly twice as high as the total number of ERb mRNA-labeled cells counted under dark-field illumination in the analyzed sections. In comparison, in the SON, 40 € 4% of ERb mRNA cells also expressed the AVP mRNA (Fig. 1B) , whereas in the same sections, only 5 € 1% of AVP mRNA-positive cells also expressed the radioactive signal for the ERb mRNA. Moreover, the total number of AVPmRNA containing cells in the SON was roughly five times greater than the total number of ERb -signal containing cells. Hence, in both the PVN and the SON, the ERb mRNA signal is contained in a smaller cell population than the AVP mRNA signal, and the colocalization between the two probes is expressed in 40-45% of the total ERb -positive cell population.
Colocalization between ERb and prepro-OFQ
The distribution of the prepro-OFQ-digoxigenin label is abundantly encountered in both the magno-and parvocellular regions of the PVN (Fig. 3A) . Dual in situ hybridization showed that 50 € 3% of ERb mRNApositive cells in the ventromedial PVN also expressed the prepro-OFQ mRNA, whereas in the same sections, only 10 € 2% of prepro-OFQ-positive cells also showed radioactive labeling for the ERb mRNA ( Fig. 1A ; Fig. 3B,C) . The total number of prepro-OFQ-labeled cells in the PVN under bright-field illumination was five times greater than the number of ERb-labeled cells under dark-field illumination in the analyzed sections. In the SON, however, even though the relative ratio of brightfield and dark-field counts revealed twice as many prepro-OFQ mRNA-positive cells than the ERb mRNA-positive cells in the analyzed sections, only 20 € 4% of the ERb mRNA-containing cells also showed expression of the prepro-OFQ mRNA ( Fig. 1B; Fig. 5A ). Similar to the PVN, only 10 € 1% of prepro-OFQ-positive cells in the SON remained colocalized with the ERb mRNA signal. Thus, as in the case of AVP, in both the PVN and SON, the ERb mRNA signal is contained in a smaller cell population than the pre-pro-OFQ mRNA signal. Moreover, although roughly 50% of the ERb mRNA-positive cells were also pre-pro-OFQ-positive in the PVN, this number dropped to 20% in the SON. The distribution of the ORL1 non-radioactive mRNA signal in the ventromedial PVN was identical to that of the prepro-OFQ as described above (Fig. 4A) . Double in situ hybridization revealed that 20 € 2% of ERb-mRNA containing cells in the PVN also expressed ORL1 mRNA, whereas in the same sections, only 10 € 3% of ORL1 mRNA-positive cells also expressed ERb mRNA ( Fig. 1A; Fig. 4B, C) . The total number of ORL1-labeled cells in the PVN counted under bright-field illumination was three times greater than the total number of ERb mRNA-positive cells counted under dark-field illumination in the analyzed sections. In comparison, in the SON, the percentage of ERb mRNA-positive cells that also contained the ORL1 mRNA dropped to 10 € 3% ( Fig. 1B;   Fig. 5B ). In addition, less than 5% of ORL1-positive cells are also found positive for the ERb mRNA. The relative ratio of the bright-field (ORL1) and dark-field (ERb) cell counts was similar to that of the prepro-OFQ in the SON as described above. As in all the comparisons before, the ERb mRNA label is found to be located in a smaller cell population than the ORL1 digoxigenin label in both the PVN and the SON. Consistent with prepro-OFQ findings above, the percentage of ERb mRNA-positive cells that also contained ORL1 digoxigenin label was higher in the PVN (around 20%) than in the SON (around 10%). Colocalization between ERb and OXY, CRH and ENK Although, the OXY mRNA signal is encountered in the same sections as the ERb mRNA signal in the PVN, double in situ hybridization showed that less than 10 € 1% of ERb mRNA-positive cells also expressed the OXY mRNA ( Fig. 1A; Fig. 6 A, B) . Moreover, in the same sections, less than 5 € 2% of OXY mRNA-positive cells also expressed the ERb mRNA. No colocalization between the ERb and OXY mRNA signals is detected in the SON. Double in situ hybridization showed that only a few scattered ERb mRNA-positive cells also expressed the CRH mRNA in the ventromedial PVN. Throughout the PVN, the ERb and the CRH mRNAs seemed to be distributed in a non-overlapping fashion. No CRH mRNA digoxigenin labeling is detected in the SON. No colocalization between the ERb mRNA and the ENK mRNA positive cells was detected due to non-overlapping distribution patterns in the PVN. No ENK mRNA digoxigenin labeling is detected in the SON.
Discussion
This study describes a significant overlap in the gene expressions of the orphanin FQ and estrogen-ERb systems, particularly in the hypothalamic nucleus that coordinates the stress/autonomic response, the PVN. Our double in situ histochemistry findings showed that roughly half of the ERb neurons in the ventromedial PVN also contained the OFQ mRNA. In addition, there was 20% overlap between the ERb and the ORL1 receptor mRNAs in the PVN. Interestingly, in the same region, the ERb mRNA coexpressions with the AVP and OXY mRNAs were 45% and 10% respectively. By contrast, the coexpression between the prepro-OFQ and the ERb mRNAs was less striking in the SON (10-20%), although the ERb mRNA was found colocalized the highest with the AVP mRNA in this region (40%). No colocalizations were detected between the ERb mRNA and the CRH and ENK mRNAs in the ventromedial PVN, and between the ERb mRNA and the OXY mRNA in the SON. These results confirm that, in addition to the AVP and OXY, estrogen may directly regulate the OFQ-ORL1 neuropeptide system in the PVN, and to a lesser degree in the SON, via its nuclear receptor b.
Both OFQ and ORL1 are found widely distributed in the central nervous system with exceptionally high densities in the hypothalamus including arcuate nucleus, suprachiasmatic nucleus, SON, PVN, ventromedial hypothalamus, and zona incerta (Neal et al. 1999a (Neal et al. , 1999b . Moreover, the OFQ is shown to act as an endogenous anxiolytic in the central nervous system in mice and rats, and to attenuate behavioral response to stressors (Jenck et al. 1997; Griebel et al. 1999) . In contrast, however, the OFQ-deficient mice have been shown to be impaired in adaptation to repeated stress (Koster et al. 1999) . In spite of the reported anxiolytic effects, in our laboratories we have shown that the OFQ administration activates the HPA axis and augments plasma adrenocorticotropin and corticosterone responses in both unstressed and stressed rats (Devine et al. 2001) . It is also shown that the OFQ is released endogenously in response to an acute stress exposure (Devine et al. 1998 ). Together, these data suggest that the OFQ system, although far from being fully understood in function, may regulate stress and anxiety responses and perhaps due to its interactions with the ERb.
It is possible that the ERb mRNA-positive neurons in the PVN and SON that colocalize with AVP, OFQ, ORL1 and OXY mRNAs constitute to overlapping neuronal populations. It is also possible that these neuropeptide systems occupy separate neuronal populations. In either case, estrogen seems to play an intricate role in regulating multiple neuropeptide systems that are synthesized in the same or neighboring neurons in the PVN and SON. It is unknown whether the OFQ-ORL1-containing neurons in the PVN and SON also express AVP and/or OXY. In case of such an overlap, it is possible that estrogen can activate different genes with different time courses so that a functional differentiation and/or integration can be achieved at projection sites. A closer look at the projection sites of specific neurons that contain the ERb mRNA in these hypothalamic regions is helpful for understanding the possible functional significance of the ERb mRNA overlap with the above neuropeptides.
The ventromedial PVN where the ERb mRNA signal is most abundant, contains parvocellular cells (i.e., medial parvocellular part) as well as magnocellular cells (i.e., posterior magnocellular part). The neuronal cell popula- tion that is ERb-positive has little or no overlap with the neuroendocrine part of the PVN. In addition to the neuroendocrine-related projections to the posterior lobe of the pituitary gland (Sherlock et al. 1975 ) and the median eminence (Vandesande et al. 1977) , the PVN also sends projections directly to a number of extrahypothalamic nuclei (Conrad and Pfaff 1976; Swanson 1977; Swanson and Kuypers 1980; Sawchenko and Swanson 1982) , which are implicated in multiple aspects of autonomic nervous system function. For example, retrograde fluorescence double-labeling studies previously showed that a significant amount of medial parvocellular and posterior magnocellular neurons that are AVP-and OXY-positive also send long descending projections to the autonomic cell groups in the medulla and spinal cord (Swanson and Kuypers 1980; Sawchenko and Swanson 1982) .
The lack of a significant colocalization between the ERb mRNA and the CRH mRNA and at the same time a high percentage of colocalization between the ERb mRNA and the prepro-OFQ mRNA in the PVN may suggest that ERb is not directly regulating the HPA axis via traditional neuroendocrine-mediated pathways. Since the ERb mRNA showed the highest expression in the ventromedial parts of the PVN, and this zone is mainly involved in the regulation of autonomic functions via caudal projections of medulla and spinal cord, it is logical to suggest that ERb, through activation of the endogenous OFQ neurons in the PVN, may regulate the autonomic nervous system to yield behaviors such as fight or flight response.
In summary, estrogen through its receptor b subtype can directly activate AVP-and OXY-containing neurons as well as a novel neuropeptide system, the OFQ-ORL1, in the two hypothalamic nuclei, the PVN and the SON. The extent of colocalization between the ERb mRNA and AVP mRNA is comparable to that of ERb mRNA and OFQ mRNA in the PVN, hence suggesting that estrogen may have as significant a role in the regulation of OFQ in this brain region. In the SON, however, the magnitude of colocalization is lower for OFQ-ORL1 but remains high with AVP. This may provide a mechanism for differential neuropeptidergic regulation of the PVN and SON by estrogen-binding to the b receptor. In both cases, the interaction between estrogen and the well-characterized AVP-OXY neurosecretory system and the novel OFQ-ORL1 opioid neuropeptide system may provide novel leads to the functional significance of ERb, specifically in stress/autonomic responses.
